HopeStage
Back to all studies
RecruitingNCT07218549

Kratom effects in people with past opioid use

About this titleRead the official source — NCT07218549
Medication studyAges 18–55United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 55 years.

Listed locations
HoustonSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: September 1, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
72
Sponsor
Christopher D. Verrico
Sponsor type
Individual investigator
Study type
Drug
Intervention type
Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT07218549
Official title
Show the full official title

Evaluation of the Safety and Effects of Psychoactive Substances in People With Past Opioid Use

Recruitment & locations

Currently recruiting

Houston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Christopher D. Verrico.

Does this study involve medication?

Yes. The study involves medication, including Placebo, Oxycodone HCl, Kratom 8g, Kratom 12g, Kratom 16g and Kratom 4g.

Who can participate?

Listed age limits: 18 years to 55 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies